Loading...
Loading chart...



The current price of APDN is 0 USD — it has increased 0 % in the last trading day.
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Wall Street analysts forecast APDN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for APDN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Applied DNA Sciences Inc revenue for the last quarter amounts to 304.00K USD, decreased -35.62 % YoY.
Applied DNA Sciences Inc. EPS for the last quarter amounts to -33.99 USD, decreased -102.90 % YoY.
Applied DNA Sciences Inc (APDN) has 46 emplpoyees as of January 31 2026.
Today APDN has the market capitalization of 4.00M USD.